Article Correctness Is Author's Responsibility: Target for Stroke Therapy in Blood-Brain Barrier Discovered

The article below may contain offensive and/or incorrect content.

This shows a brain scanThe stroke byproduct acrolein activates the precursor of heparanase, an enzyme that degrades the glycocalyx in the blood-brain barrier.